Filed: 5/15/2025ACC: 0001977548-25-000005
π What this filing means
CHECKPOINT CAPITAL L.P. filed this quarterly 13FβHR report disclosing 14 equity positions with a total reported market value of $182.27M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$182.27M
Total AUM (reported)
5.94M
Total Shares
Allocation by class
COM$111.69M61.3%
SPONSORED ADR$68.06M37.3%
COM NEW$2.25M1.2%
ADS$267.4K0.1%
Portfolio Concentration
Top 3$129.98M71.3%
4β10$49.06M26.9%
11β25$3.22M1.8%
Top 3 weight
71.3%
Top 10 weight
98.2%
Voting Authority Distribution
Total shares with voting rights: 5.94M
Sole
Full voting authority
5.94M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings14
Rows:
ARGENX SE
SOLEShares115K
TypeSH
Market value$68.06M
37.34%
Sole
115K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares907.24K
TypeSH
Market value$48.06M
26.37%
Sole
907.24K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares392.01K
TypeSH
Market value$13.86M
7.61%
Sole
392.01K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares172.90K
TypeSH
Market value$12.35M
6.78%
Sole
172.90K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares243.31K
TypeSH
Market value$12.08M
6.63%
Sole
243.31K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares175.18K
TypeSH
Market value$8.47M
4.65%
Sole
175.18K
Shared
0.00
None
0.00
STOKE THERAPEUTICS INC
SOLEShares730.72K
TypeSH
Market value$4.86M
2.67%
Sole
730.72K
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares824.88K
TypeSH
Market value$4.78M
2.62%
Sole
824.88K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares136.60K
TypeSH
Market value$3.74M
2.05%
Sole
136.60K
Shared
0.00
None
0.00
TSCAN THERAPEUTICS INC
SOLEShares2.02M
TypeSH
Market value$2.78M
1.53%
Sole
2.02M
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares104.38K
TypeSH
Market value$2.25M
1.23%
Sole
104.38K
Shared
0.00
None
0.00
CORCEPT THERAPEUTICS INC
SOLEShares5K
TypeSH
Market value$571.1K
0.31%
Sole
5K
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares9.01K
TypeSH
Market value$267.4K
0.15%
Sole
9.01K
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares109.83K
TypeSH
Market value$134.0K
0.07%
Sole
109.83K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARGENX SESOLE | SPONSORED ADR | 115K | SH | $68.06M 37.34% | 115K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 907.24K | SH | $48.06M 26.37% | 907.24K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 392.01K | SH | $13.86M 7.61% | 392.01K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 172.90K | SH | $12.35M 6.78% | 172.90K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 243.31K | SH | $12.08M 6.63% | 243.31K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 175.18K | SH | $8.47M 4.65% | 175.18K | 0.00 | 0.00 |
STOKE THERAPEUTICS INCSOLE | COM | 730.72K | SH | $4.86M 2.67% | 730.72K | 0.00 | 0.00 |
SEPTERNA INCSOLE | COM | 824.88K | SH | $4.78M 2.62% | 824.88K | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 136.60K | SH | $3.74M 2.05% | 136.60K | 0.00 | 0.00 |
TSCAN THERAPEUTICS INCSOLE | COM | 2.02M | SH | $2.78M 1.53% | 2.02M | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 104.38K | SH | $2.25M 1.23% | 104.38K | 0.00 | 0.00 |
CORCEPT THERAPEUTICS INCSOLE | COM | 5K | SH | $571.1K 0.31% | 5K | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 9.01K | SH | $267.4K 0.15% | 9.01K | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 109.83K | SH | $134.0K 0.07% | 109.83K | 0.00 | 0.00 |